RECQL4 Gene
The RECQL4 gene plays a crucial role in maintaining the integrity of our genetic material, acting as a vital component in DNA repair pathways. Understanding this gene is essential for comprehending its impact on human health and disease.

Key Takeaways
- The RECQL4 gene encodes a DNA helicase critical for genome stability.
- It is involved in DNA replication, repair, and recombination processes.
- Mutations in RECQL4 are primarily associated with rare genetic disorders like Rothmund-Thomson Syndrome.
- Dysfunction of RECQL4 can lead to increased cancer risk and developmental abnormalities.
- Research into RECQL4 helps in diagnosing and managing associated conditions.
What is the RECQL4 Gene and its Function?
The RECQL4 Gene is a member of the RecQ helicase family, a group of enzymes known for their critical role in maintaining genomic stability. Located on chromosome 8, this gene provides instructions for making a protein that functions as a DNA helicase. DNA helicases are enzymes that unwind the double helix structure of DNA, a process essential for various cellular activities, including DNA replication, repair, and recombination.
The RECQL4 gene function and importance lie in its multifaceted involvement in these fundamental processes. It is particularly crucial for the base excision repair (BER) pathway, a primary mechanism for repairing damaged DNA bases. Additionally, the RECQL4 protein is involved in homologous recombination and non-homologous end-joining, both critical for repairing double-strand breaks in DNA. By facilitating these repair mechanisms, the RECQL4 gene helps prevent the accumulation of mutations and chromosomal abnormalities, thereby safeguarding the cell’s genetic information. Its role extends to mitochondrial DNA maintenance, highlighting its broad impact on cellular health and function.
RECQL4 Gene Mutations and Associated Conditions
Mutations in the RECQL4 gene can have significant health consequences, primarily due to the disruption of its vital DNA repair functions. The RECQL4 gene mutation effects often manifest as genomic instability, increased sensitivity to DNA-damaging agents, and a predisposition to various developmental abnormalities and cancers. These mutations can lead to a non-functional or abnormally structured RECQL4 protein, impairing the cell’s ability to repair DNA damage effectively.
The most well-known of the RECQL4 gene associated diseases is Rothmund-Thomson Syndrome (RTS), an extremely rare genetic disorder. RTS is characterized by a distinctive skin rash (poikiloderma), skeletal abnormalities, sparse hair, cataracts, and a significantly increased risk of certain cancers, particularly osteosarcoma and squamous cell carcinoma. Other rare conditions linked to RECQL4 mutations include RAPADILINO syndrome (characterized by radial ray defects, patellar hypoplasia or aplasia, diarrhea, and other features) and Baller-Gerold syndrome (which involves craniosynostosis and radial ray defects). While distinct, these syndromes share overlapping clinical features with RTS, underscoring the central role of RECQL4 in diverse developmental pathways and cancer surveillance. According to the National Institutes of Health, fewer than 300 cases of Rothmund-Thomson Syndrome have been reported worldwide, highlighting its rarity.
Individuals with RECQL4 mutations require careful medical management, including regular screenings for cancer and ophthalmological examinations. Genetic counseling is also important for affected families to understand the inheritance patterns and risks associated with these conditions.



















